Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the industrial & environmental ...

During Q1 2025, the Harbor Long-Short Equity ETF returned 5.23% (NAV), outperforming its benchmark, the HRFX Equity Hedge ...

Beverage company Zevia (NYSE:ZVIA) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 2% ...

It isn't a bad business model, but the U.S. market is largely saturated. Competition is fierce, and more and more ways to buy medication now exist, exacerbating the issue. They include grocery stores, ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer retail industry, ...